Back

Protective effect of clusterin on doxorubicin induced myocardial damage

30 August 2016 (16:10 - 16:17)
Organised by:
Congress Presentation Part of: Cancer and cardiotoxicity: from bench to bedside Cardiotoxicity of drugs ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Jung Ha Lee

Dongguk University International Hospital, Goyang (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles
Doctor R. Wurm (Vienna, AT)
Abstract Slides
Presentation thumbnail
Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity in vitro and in vivo
Miss H. Cho (Seoul, KR)
Abstract
Presentation thumbnail
TCTP down-regulation induced cardiac cell death through Bnip3 may be a pivotal mechanism of Doxorubicin-induced heart failure
Ms W. Cai (Guangzhou, CN)
Abstract
Presentation thumbnail
CCAAT/enhancer binding protein delta contributes to an earlier phase of pro-inflammatory response in doxorubicin related cardiomyopathy
Professor P. Liu (Tainan, TW)
Abstract
Presentation thumbnail
Cardioprotective effect of taurine against doxorubicin cardiotoxicity in rats: echocardiographic and histologic study
Doctor V. Baris (Gaziantep, TR)

Access the full session

Session thumbnail
Cancer and cardiotoxicity: from bench to bedside

The Event

Event poster

ESC Congress 2016

30 August 2016 16:10 CET
You may be interested in
thumbnail
Congress Presentation
Unveiling doxorubicin-induced cardiotoxicity: into the heart with single-cell resolution
20 June 2025
thumbnail
Webinar
Multidisciplinary strategies for monitoring and managing cardiovascular toxicity in patients with cancer
18 February 2025
thumbnail
Congress Presentation
Biomimetic nanozymes target the heart to suppress ferroptosis for ameliorating doxorubicin-induced cardiotoxicity via synergetic effect of antioxidant stress and Nrf2/Hmox1 inhibition
25 August 2023
thumbnail
ESC Journals
Cardio-protective effect of trimetazidine in patients with disseminated breast cancer
24 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources